* Biogen Idec’s Tecfidera drug to treat multiple sclerosis more than doubled in 3Q 2014 to $787 million despite missing analysts estimates of $794 million. Biogen boosted its full-year adjusted earnings forecast for the third quarter in a row, to $13.45 to $13.55 per share, from $12.90 to $13.10 per share. Biogen Idec’s 3Q net income rose […]
Blog Videos
* Global mobile advertising may rise 85% to about $33 billion in 2014, according to EMarketer. In the U.S., mobile ads may grow about 83%, which has been helped by an increase in online video format. Mobile spending rose 122% last year in the U.S. vs. a 3% increase in desktop ads, as users spend […]
* Estimates for 3Q point to Gilead again outpacing its mature biotech peers on EPS and sales growth. While Sovaldi is driving much of this, the warehousing effect seen in 3Q means its U.S. contribution is likely to be less vs. 2Q, meaning analysts are expecting more substantial EU growth * Strategy: Gilead Sciences: Buy. […]
* Apple will have 40 stores in the greater China area, from 15 now, CEO Tim Cook told Chinese media in an interview that was published live by Sina. • It’s only a “matter of time” before China is Apple’s largest market by sales: Cook • Apple has 750,000 iOS developers in China: Cook * Strategies: * Apple Dec $100 Call […]
* The teaser trailer for Marvel’s Avengers Age of Ultron was originally going to debut with the next episode of Marvel’s Agents of SHIELD on ABC. But someone leaked the international version of the trailer (blame Hyrda) and now Marvel has officially released the first trailer for the next Avengers film a few days early * […]